2026/2027 ELITE
RESEARCH REPORT &
TEST BANK: HAM’S
PRIMARY CARE
GERIATRICS (v9.0)
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Critical Action" Cheat Sheet
○ The 2026/2027 Standards Architecture
● PART II: THE ELITE TEST BANK
○ Questions 1–28: Foundational Syntax & Application (Pathophysiology, 4Ms, Beers
Criteria 2026)
○ Questions 29–58: Professional Simulation (Clinical Protocols, Diagnostics,
Escalation)
○ Questions 59–88: Grandmaster Synthesis (Multimorbidity, Deprescribing
Cascades, Advanced Directives)
PART I: THE PRIMER
Welcome to the big leagues. This is not a repository of academic trivia; it is a clinical forge
designed to intercept high-stakes iatrogenic errors before they reach the patient. By mastering
this test bank, grounded in the clinical realities of Ham’s Primary Care Geriatrics, you will
synthesize the 2026/2027 geriatric standards into rapid, infallible professional intuition. You will
elevate your practice from merely competent to master-level architectural care, capable of
untangling the most severe prescribing cascades and atypical presentations.
The "Critical Action" Cheat Sheet
● The 2026 PREVENT Protocol: The Pooled Cohort Equations (PCE) are obsolete.
Cardiovascular risk is now calculated via PREVENT, which incorporates eGFR, HbA1c,
and social deprivation index (SDI), explicitly removing race as a variable.
● The GOLD Group E Escalation: COPD classification is aggressively proactive. A single
, moderate exacerbation reclassifies a patient to Group E. IMMEDIATE escalation to
LAMA/LABA is mandated; add an inhaled corticosteroid (ICS) only if blood eosinophils
are \ge 300 cells/\muL.
● The "Severe Asymptomatic Hypertension" Rule: The term "Hypertensive Urgency" is
retired. In asymptomatic patients with severe hypertension, NEVER drop pressure acutely
with IV medications. Initiate oral therapy and follow up in 24–72 hours to prevent
watershed strokes.
● The 2025/2026 Beers Criteria "Alternatives" Mandate: Identifying a potentially
inappropriate medication (PIM) is no longer sufficient. You must implement
evidence-based alternatives. Replace Z-drugs with CBT-I. Replace typical antipsychotics
in dementia with non-pharmacologic behavioral de-escalation.
● The 4Ms Framework: What Matters, Medication, Mentation, Mobility. Every geriatric
encounter must actively screen and optimize these four pillars to maintain Age-Friendly
Health Systems accreditation, a standard championed by institutions like UT Health
Austin.
The 2026/2027 Standards Architecture
Clinical Domain 2023/Legacy Standard 2026/2027 Elite Implementation
Cardiovascular Risk PCE (Pooled Cohort Equations) PREVENT Calculator; utilizes
utilizing race. eGFR, HbA1c, SDI. Race
excluded.
COPD Escalation Two exacerbations required for Single moderate exacerbation
high-risk categorization. triggers Group E (LAMA/LABA
dual therapy).
Insomnia Management Taper Z-drugs; tolerate mild Mandatory transition to CBT-I
sleep loss. (Cognitive Behavioral Therapy
for Insomnia).
Pain in CKD NSAID avoidance; reliance on Topical NSAIDs and targeted
tramadol/opioids. SNRI/Gabapentinoid titration.
Advance Directives (TX) Standard DNR orders used Strict adherence to OOH-DNR
interchangeably. (Chapter 166) for pre-hospital
EMS.
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: An 84-year-old female presents with chronic insomnia. Her medication list includes
Zolpidem 5mg nightly. According to the 2025/2026 AGS Beers Criteria Alternatives List, which
intervention is the MOST APPROPRIATE INITIAL action? A) Reduce the Zolpidem dose to
2.5mg to minimize renal clearance burden. B) Discontinue Zolpidem and initiate
Diphenhydramine 25mg nightly. C) Initiate a supervised taper of Zolpidem and prescribe
Cognitive Behavioral Therapy for Insomnia (CBT-I). D) Transition the patient to a short-acting
benzodiazepine like Lorazepam.
● The Answer: C (Initiate a supervised taper of Zolpidem and prescribe Cognitive
Behavioral Therapy for Insomnia (CBT-I).)
● Distractor Analysis: * A is incorrect: Dose reduction does not eliminate the severe
, fall/fracture risk inherent to Z-drugs. * B & D are incorrect: Both Diphenhydramine
(anticholinergic) and Lorazepam (benzodiazepine) are highly restricted Beers Criteria
medications that worsen mentation and mobility.
The Mentor's Analysis: The 2026 update to the Beers Criteria shifted the paradigm from
merely "avoiding" drugs to actively implementing the "Alternatives List". Z-drugs cause
catastrophic falls and delirium. The hard rule is non-pharmacologic intervention first.
Professional Intuition: Sleep hygiene and CBT-I are the only frontline insomnia treatments for
the geriatric phenotype.
Q2: A 76-year-old male with a history of COPD experiences his first moderate exacerbation
requiring oral corticosteroids, without hospitalization. Under 2026 GOLD guidelines, which
classification and treatment adjustment is MANDATED? A) Maintain current LAMA
monotherapy as he did not require intubation. B) Reclassify to GOLD Group E and initiate dual
LAMA/LABA therapy. C) Reclassify to GOLD Group B and initiate PRN short-acting
bronchodilators. D) Immediately initiate triple therapy (LAMA/LABA/ICS) regardless of biomarker
status.
● The Answer: B (Reclassify to GOLD Group E and initiate dual LAMA/LABA therapy.)
● Distractor Analysis: * A & C are incorrect: The 2026 guidelines removed the
two-exacerbation threshold; a single moderate exacerbation proves the patient is
high-risk.
○ D is incorrect: Triple therapy requires a specific biological target (blood eosinophils
\ge 300 cells/\muL).
The Mentor's Analysis: In 2026, the respiratory community recognized that waiting for a
second COPD exacerbation is therapeutic negligence. One moderate event increases
subsequent risk by 300%. The immediate structural response is maximal bronchodilation via
dual therapy. Professional Intuition: Never wait for the lungs to fail twice.
Q3: You are assessing a 70-year-old patient's cardiovascular risk. The clinic's electronic health
record has just integrated the 2026 AHA guidelines. Which data point is now EXCLUDED from
the primary prevention risk calculation? A) Estimated Glomerular Filtration Rate (eGFR) B)
Patient's self-reported race C) Hemoglobin A1c (HbA1c) D) Social Deprivation Index (SDI)
● The Answer: B (Patient's self-reported race)
● Distractor Analysis: * A, C, and D are incorrect: The PREVENT calculator explicitly
incorporates eGFR, HbA1c, and SDI to build a comprehensive
Cardiovascular-Kidney-Metabolic (CKM) profile. Race was definitively removed as a
biological proxy in favor of precise social and metabolic metrics.
The Mentor's Analysis: The Pooled Cohort Equations (PCE) were retired because they relied
on race—a social construct—as a flawed biological variable. The PREVENT calculator bridges
the gap between cardiology and nephrology. Professional Intuition: In modern geriatrics, the
kidneys and the heart are the exact same system.
Q4: A 79-year-old female arrives for a routine follow-up. Her blood pressure is 188/110 mmHg.
She is fully alert, conversant, and denies chest pain, dyspnea, or headache. What is the
SAFEST NEXT step in management? A) Administer IV Hydralazine in the clinic to drop the
systolic pressure below 140 mmHg. B) Send the patient immediately to the Emergency
Department for a stat head CT. C) Administer a sublingual Nifedipine capsule to achieve rapid
vasodilation. D) Adjust her oral antihypertensives and schedule an outpatient follow-up within 24
to 72 hours.
● The Answer: D (Adjust her oral antihypertensives and schedule an outpatient follow-up
within 24 to 72 hours.)
● Distractor Analysis: * A & C are incorrect: Using rapid-acting IV or sublingual agents in
, an asymptomatic patient causes sudden cerebral hypoperfusion, directly precipitating
iatrogenic strokes.
○ B is incorrect: Without focal neurologic deficits or end-organ damage, ED referral is
unwarranted.
The Mentor's Analysis: "Hypertensive Urgency" is a ghost concept. We now call it Severe
Asymptomatic Hypertension. The patient's cerebral autoregulation is accustomed to high
pressures. Crashing the pressure starves the brain of oxygen. Professional Intuition: A steady,
gradual reduction over days is the only acceptable physiological approach.
Q5: A 68-year-old male with a history of COPD presents for hospital discharge planning.
According to the 2026 GOLD Report and CDC guidelines, which immunization is now a
STRONG RECOMMENDATION to prevent fatal exacerbations? A) Respiratory Syncytial Virus
(RSV) vaccine B) Live-attenuated Influenza vaccine (LAIV) C) Human Papillomavirus (HPV)
vaccine D) Haemophilus influenzae type b (Hib) vaccine
● The Answer: A (Respiratory Syncytial Virus (RSV) vaccine)
● Distractor Analysis: * B is incorrect: Live vaccines are generally contraindicated or less
preferred in fragile, chronic lung disease populations compared to inactivated forms.
○ C & D are incorrect: These do not address the primary viral drivers of geriatric
COPD exacerbations.
The Mentor's Analysis: RSV is no longer just a pediatric concern; in narrowed,
emphysematous airways, RSV triggers profound, often fatal, inflammatory cascades. By 2026,
the RSV vaccine became standard protocol for adults \ge 60 with structural lung disease.
Professional Intuition: Prevention is the ultimate bronchodilator.
Q6: A 72-year-old patient with Parkinson's disease experiences severe, progressive
hallucinations. The family requests medication. According to the 2026 AGS Beers Alternatives,
which class of medication must be STRICTLY AVOIDED due to high risk of irreversible motor
decline? A) First-generation typical antipsychotics (e.g., Haloperidol) B) Cholinesterase
inhibitors (e.g., Donepezil) C) Selective Serotonin Reuptake Inhibitors (e.g., Sertraline) D)
N-methyl-D-aspartate receptor antagonists (e.g., Memantine)
● The Answer: A (First-generation typical antipsychotics (e.g., Haloperidol))
● Distractor Analysis: * B, C, and D are incorrect: While these have side effects, they do
not directly and catastrophically block dopamine receptors in the basal ganglia like typical
antipsychotics do.
The Mentor's Analysis: Parkinson's is a dopamine-deficit state. Administering a dopamine
antagonist like Haloperidol to "calm" hallucinations effectively paralyses the patient, triggering
severe extrapyramidal symptoms. Professional Intuition: Treating the mind must never destroy
the body's mobility.
Q7: Under the "4Ms" Age-Friendly Health Systems framework, a clinic implements a protocol
asking every patient: "What is your primary goal for your health this year?" This specifically
addresses which "M"? A) Mobility B) Mentation C) What Matters D) Medication
● The Answer: C (What Matters)
● Distractor Analysis: * A, B, and D are incorrect: These represent the other core pillars.
"What Matters" is the foundational anchor that dictates how the other three pillars are
managed.
The Mentor's Analysis: You cannot design a care plan without a destination. If a patient's
primary goal is attending a granddaughter's wedding, aggressive chemotherapy that leaves
them bedbound violates the "What Matters" mandate. Professional Intuition: Clinical
algorithms serve the patient's values, not the other way around.
Q8: An 88-year-old male is brought to the clinic by his daughter. He has a history of mild
RESEARCH REPORT &
TEST BANK: HAM’S
PRIMARY CARE
GERIATRICS (v9.0)
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Critical Action" Cheat Sheet
○ The 2026/2027 Standards Architecture
● PART II: THE ELITE TEST BANK
○ Questions 1–28: Foundational Syntax & Application (Pathophysiology, 4Ms, Beers
Criteria 2026)
○ Questions 29–58: Professional Simulation (Clinical Protocols, Diagnostics,
Escalation)
○ Questions 59–88: Grandmaster Synthesis (Multimorbidity, Deprescribing
Cascades, Advanced Directives)
PART I: THE PRIMER
Welcome to the big leagues. This is not a repository of academic trivia; it is a clinical forge
designed to intercept high-stakes iatrogenic errors before they reach the patient. By mastering
this test bank, grounded in the clinical realities of Ham’s Primary Care Geriatrics, you will
synthesize the 2026/2027 geriatric standards into rapid, infallible professional intuition. You will
elevate your practice from merely competent to master-level architectural care, capable of
untangling the most severe prescribing cascades and atypical presentations.
The "Critical Action" Cheat Sheet
● The 2026 PREVENT Protocol: The Pooled Cohort Equations (PCE) are obsolete.
Cardiovascular risk is now calculated via PREVENT, which incorporates eGFR, HbA1c,
and social deprivation index (SDI), explicitly removing race as a variable.
● The GOLD Group E Escalation: COPD classification is aggressively proactive. A single
, moderate exacerbation reclassifies a patient to Group E. IMMEDIATE escalation to
LAMA/LABA is mandated; add an inhaled corticosteroid (ICS) only if blood eosinophils
are \ge 300 cells/\muL.
● The "Severe Asymptomatic Hypertension" Rule: The term "Hypertensive Urgency" is
retired. In asymptomatic patients with severe hypertension, NEVER drop pressure acutely
with IV medications. Initiate oral therapy and follow up in 24–72 hours to prevent
watershed strokes.
● The 2025/2026 Beers Criteria "Alternatives" Mandate: Identifying a potentially
inappropriate medication (PIM) is no longer sufficient. You must implement
evidence-based alternatives. Replace Z-drugs with CBT-I. Replace typical antipsychotics
in dementia with non-pharmacologic behavioral de-escalation.
● The 4Ms Framework: What Matters, Medication, Mentation, Mobility. Every geriatric
encounter must actively screen and optimize these four pillars to maintain Age-Friendly
Health Systems accreditation, a standard championed by institutions like UT Health
Austin.
The 2026/2027 Standards Architecture
Clinical Domain 2023/Legacy Standard 2026/2027 Elite Implementation
Cardiovascular Risk PCE (Pooled Cohort Equations) PREVENT Calculator; utilizes
utilizing race. eGFR, HbA1c, SDI. Race
excluded.
COPD Escalation Two exacerbations required for Single moderate exacerbation
high-risk categorization. triggers Group E (LAMA/LABA
dual therapy).
Insomnia Management Taper Z-drugs; tolerate mild Mandatory transition to CBT-I
sleep loss. (Cognitive Behavioral Therapy
for Insomnia).
Pain in CKD NSAID avoidance; reliance on Topical NSAIDs and targeted
tramadol/opioids. SNRI/Gabapentinoid titration.
Advance Directives (TX) Standard DNR orders used Strict adherence to OOH-DNR
interchangeably. (Chapter 166) for pre-hospital
EMS.
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: An 84-year-old female presents with chronic insomnia. Her medication list includes
Zolpidem 5mg nightly. According to the 2025/2026 AGS Beers Criteria Alternatives List, which
intervention is the MOST APPROPRIATE INITIAL action? A) Reduce the Zolpidem dose to
2.5mg to minimize renal clearance burden. B) Discontinue Zolpidem and initiate
Diphenhydramine 25mg nightly. C) Initiate a supervised taper of Zolpidem and prescribe
Cognitive Behavioral Therapy for Insomnia (CBT-I). D) Transition the patient to a short-acting
benzodiazepine like Lorazepam.
● The Answer: C (Initiate a supervised taper of Zolpidem and prescribe Cognitive
Behavioral Therapy for Insomnia (CBT-I).)
● Distractor Analysis: * A is incorrect: Dose reduction does not eliminate the severe
, fall/fracture risk inherent to Z-drugs. * B & D are incorrect: Both Diphenhydramine
(anticholinergic) and Lorazepam (benzodiazepine) are highly restricted Beers Criteria
medications that worsen mentation and mobility.
The Mentor's Analysis: The 2026 update to the Beers Criteria shifted the paradigm from
merely "avoiding" drugs to actively implementing the "Alternatives List". Z-drugs cause
catastrophic falls and delirium. The hard rule is non-pharmacologic intervention first.
Professional Intuition: Sleep hygiene and CBT-I are the only frontline insomnia treatments for
the geriatric phenotype.
Q2: A 76-year-old male with a history of COPD experiences his first moderate exacerbation
requiring oral corticosteroids, without hospitalization. Under 2026 GOLD guidelines, which
classification and treatment adjustment is MANDATED? A) Maintain current LAMA
monotherapy as he did not require intubation. B) Reclassify to GOLD Group E and initiate dual
LAMA/LABA therapy. C) Reclassify to GOLD Group B and initiate PRN short-acting
bronchodilators. D) Immediately initiate triple therapy (LAMA/LABA/ICS) regardless of biomarker
status.
● The Answer: B (Reclassify to GOLD Group E and initiate dual LAMA/LABA therapy.)
● Distractor Analysis: * A & C are incorrect: The 2026 guidelines removed the
two-exacerbation threshold; a single moderate exacerbation proves the patient is
high-risk.
○ D is incorrect: Triple therapy requires a specific biological target (blood eosinophils
\ge 300 cells/\muL).
The Mentor's Analysis: In 2026, the respiratory community recognized that waiting for a
second COPD exacerbation is therapeutic negligence. One moderate event increases
subsequent risk by 300%. The immediate structural response is maximal bronchodilation via
dual therapy. Professional Intuition: Never wait for the lungs to fail twice.
Q3: You are assessing a 70-year-old patient's cardiovascular risk. The clinic's electronic health
record has just integrated the 2026 AHA guidelines. Which data point is now EXCLUDED from
the primary prevention risk calculation? A) Estimated Glomerular Filtration Rate (eGFR) B)
Patient's self-reported race C) Hemoglobin A1c (HbA1c) D) Social Deprivation Index (SDI)
● The Answer: B (Patient's self-reported race)
● Distractor Analysis: * A, C, and D are incorrect: The PREVENT calculator explicitly
incorporates eGFR, HbA1c, and SDI to build a comprehensive
Cardiovascular-Kidney-Metabolic (CKM) profile. Race was definitively removed as a
biological proxy in favor of precise social and metabolic metrics.
The Mentor's Analysis: The Pooled Cohort Equations (PCE) were retired because they relied
on race—a social construct—as a flawed biological variable. The PREVENT calculator bridges
the gap between cardiology and nephrology. Professional Intuition: In modern geriatrics, the
kidneys and the heart are the exact same system.
Q4: A 79-year-old female arrives for a routine follow-up. Her blood pressure is 188/110 mmHg.
She is fully alert, conversant, and denies chest pain, dyspnea, or headache. What is the
SAFEST NEXT step in management? A) Administer IV Hydralazine in the clinic to drop the
systolic pressure below 140 mmHg. B) Send the patient immediately to the Emergency
Department for a stat head CT. C) Administer a sublingual Nifedipine capsule to achieve rapid
vasodilation. D) Adjust her oral antihypertensives and schedule an outpatient follow-up within 24
to 72 hours.
● The Answer: D (Adjust her oral antihypertensives and schedule an outpatient follow-up
within 24 to 72 hours.)
● Distractor Analysis: * A & C are incorrect: Using rapid-acting IV or sublingual agents in
, an asymptomatic patient causes sudden cerebral hypoperfusion, directly precipitating
iatrogenic strokes.
○ B is incorrect: Without focal neurologic deficits or end-organ damage, ED referral is
unwarranted.
The Mentor's Analysis: "Hypertensive Urgency" is a ghost concept. We now call it Severe
Asymptomatic Hypertension. The patient's cerebral autoregulation is accustomed to high
pressures. Crashing the pressure starves the brain of oxygen. Professional Intuition: A steady,
gradual reduction over days is the only acceptable physiological approach.
Q5: A 68-year-old male with a history of COPD presents for hospital discharge planning.
According to the 2026 GOLD Report and CDC guidelines, which immunization is now a
STRONG RECOMMENDATION to prevent fatal exacerbations? A) Respiratory Syncytial Virus
(RSV) vaccine B) Live-attenuated Influenza vaccine (LAIV) C) Human Papillomavirus (HPV)
vaccine D) Haemophilus influenzae type b (Hib) vaccine
● The Answer: A (Respiratory Syncytial Virus (RSV) vaccine)
● Distractor Analysis: * B is incorrect: Live vaccines are generally contraindicated or less
preferred in fragile, chronic lung disease populations compared to inactivated forms.
○ C & D are incorrect: These do not address the primary viral drivers of geriatric
COPD exacerbations.
The Mentor's Analysis: RSV is no longer just a pediatric concern; in narrowed,
emphysematous airways, RSV triggers profound, often fatal, inflammatory cascades. By 2026,
the RSV vaccine became standard protocol for adults \ge 60 with structural lung disease.
Professional Intuition: Prevention is the ultimate bronchodilator.
Q6: A 72-year-old patient with Parkinson's disease experiences severe, progressive
hallucinations. The family requests medication. According to the 2026 AGS Beers Alternatives,
which class of medication must be STRICTLY AVOIDED due to high risk of irreversible motor
decline? A) First-generation typical antipsychotics (e.g., Haloperidol) B) Cholinesterase
inhibitors (e.g., Donepezil) C) Selective Serotonin Reuptake Inhibitors (e.g., Sertraline) D)
N-methyl-D-aspartate receptor antagonists (e.g., Memantine)
● The Answer: A (First-generation typical antipsychotics (e.g., Haloperidol))
● Distractor Analysis: * B, C, and D are incorrect: While these have side effects, they do
not directly and catastrophically block dopamine receptors in the basal ganglia like typical
antipsychotics do.
The Mentor's Analysis: Parkinson's is a dopamine-deficit state. Administering a dopamine
antagonist like Haloperidol to "calm" hallucinations effectively paralyses the patient, triggering
severe extrapyramidal symptoms. Professional Intuition: Treating the mind must never destroy
the body's mobility.
Q7: Under the "4Ms" Age-Friendly Health Systems framework, a clinic implements a protocol
asking every patient: "What is your primary goal for your health this year?" This specifically
addresses which "M"? A) Mobility B) Mentation C) What Matters D) Medication
● The Answer: C (What Matters)
● Distractor Analysis: * A, B, and D are incorrect: These represent the other core pillars.
"What Matters" is the foundational anchor that dictates how the other three pillars are
managed.
The Mentor's Analysis: You cannot design a care plan without a destination. If a patient's
primary goal is attending a granddaughter's wedding, aggressive chemotherapy that leaves
them bedbound violates the "What Matters" mandate. Professional Intuition: Clinical
algorithms serve the patient's values, not the other way around.
Q8: An 88-year-old male is brought to the clinic by his daughter. He has a history of mild
